Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 1;49(6):16-30.
doi: 10.15586/aei.v49i6.484. eCollection 2021.

Study on the molecular mechanism of Guizhi Jia Shaoyao decoction for the treatment of knee osteoarthritis by utilizing network pharmacology and molecular docking technology

Pin Deng  1 , Huan Liang  1 , Kunming Xie  1 , Jinglu Han  1 , Fasen Huang  1 , Huanyu Liu  2 , Hanjie Zhu  1 , Zhichao Huang  1 , Qiong Wu  1 , Jingwei Tao  1 , Lan Li  3 , Zhaojun Chen  4
Affiliations

Study on the molecular mechanism of Guizhi Jia Shaoyao decoction for the treatment of knee osteoarthritis by utilizing network pharmacology and molecular docking technology

Pin Deng et al. Allergol Immunopathol (Madr). .

Abstract

Background and objective: Guizhi Jia Shaoyao decoction (GSD) is widely used in the clinical treatment of knee osteoarthritis (KOA). However, the underlying molecular mechanisms remain unclear. The aim of this study was to explore functional mechanisms of GSD in treating KOA by utilizing network pharmacology-based approaches.

Methods: Candidate components and targets of GSD were retrieved from the Traditional Chinese Medicine Systems Pharmacology database. NCBI, Genecards, Drugbank, and Therapeutic Target Database (TTD) were used to establish a target database for KOA. Then, an interactive network diagram of "drugs-active components-targets" was plotted with Cytoscape open source bioinformatics software. A protein-protein interaction network was constructed and related protein interaction relationships were analyzed based on the STRING database. Gene ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway-enrichment analysis were conducted based on intersected targets. Molecular docking provided an assessment tool for verifying binding of components and targets. It was performed by AutoDock molecular modeling simulation software.

Results: In all, 103 active components were successfully identified, and corresponding 133 targets were searched for treating KOA. Functional enrichment analysis suggested that GSD exerts its pharmacological effect in treating KOA by regulating multiple pathways, such as PI3K-Akt, tumor necrosis factor, Toll-like receptor (TLR), and nuclear factor kappa B signaling pathways. Molecular docking analysis depicted that representative components bound firmly to key targets.

Conclusion: This study revealed the synergistic effects of multiple components, targets, and pathways of GSD for treating KOA. This would enhance the understanding of potential molecular mechanisms of GSD for treating KOA and lay a foundation for further experimental research.

Keywords: Guizhi Jia Shaoyao Decoction; Knee Osteoarthritis; Molecular Docking; Network Pharmacology; Targets.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

References

    1. 1. Huang Z, Shi X, Li X, Zhang L, Wu P, Mao J, et al. Network pharmacology approach to uncover the mechanism governing the effect of simiao powder on knee osteoarthritis. Biomed Res Int. 2020;2020(0):1–13. 10.1155/2020/6971503 - DOI
    1. 2. Chen W. Guidelines for TCM diagnosis and treatment of knee osteoarthritis, 2020 edition. Traditl Chin Med Bone Setting. 2020;10(32):1–2. 10.4103/wjtcm.wjtcm_30_19 - DOI
    1. 3. Zhao Z, Dai XS, Wang ZY, Bao ZQ, Guan JZ. MicroRNA-26a reduces synovial inflammation and cartilage injury in osteoarthritis of knee joints through impairing the NF-kappaB signaling pathway. Biosci Rep. 2019;39(4):2–16. 10.1042/BSR20182025 - DOI
    1. 4. Georgiev T, Angelov AK. Modifiable risk factors in knee osteoarthritis: Treatment implications. Rheumatol Int. 2019;39(7):1145–57. 10.1007/s00296-019-04290-z - DOI
    1. 5. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–74. 10.1002/acr.21596 - DOI

MeSH terms

Substances

LinkOut - more resources